BackAlterity Therapeutics Limited Overview

Alterity Therapeutics Limited Profit Margin

Alterity Therapeutics Limited (ATH.AX) has a profit margin of -689.83%, below the Healthcare sector average of 21.75%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Jun 2026

Annual Profit Margin (TTM)

-689.83%
↑ 49.11% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Alterity Therapeutics Limited (ATH.AX) FAQ

The latest profit margin for ATH.AX is -689.83% as of June 2026. That compares with -1355.66% in the prior-year period — up 49.1% year over year. That is below the Healthcare sector average of 21.75%. Investors often review this figure alongside Alterity Therapeutics Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, ATH.AX's profit margin moved from -1355.66% to -689.83% — a 49.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Alterity Therapeutics Limited's valuation or profitability profile.

Against Healthcare companies, ATH.AX currently prints -689.83% for profit margin, while the sector average sits near 21.75%. That is roughly 3272.1% below the sector mean. Large gaps often invite a closer look at Alterity Therapeutics Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Alterity Therapeutics Limited converts resources into returns. At -689.83%, ATH.AX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1355.66% in the prior-year period — up 49.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ATH.AX's profit margin (-689.83%), review year-over-year change from -1355.66%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers